News Digest / Ticker: TEVA

Ticker: TEVA

08:32am, Thursday, May 29, 2025

Teva Pharmaceuticals Sets Ambitious Financial Goals: Aiming for 30% Operating Margin and $3.5 Billion Cash Flow by 2030

Teva Pharmaceutical Industries (NYSE: TEVA) aims for a 30% operating profit margin by 2027, driven by product innovation and a solid generics sector. The company projects over $2.7 billion in free cash flow and $700 million in savings through operational efficiencies.